Cambridge: Atavistik Bio, a biotechnology company has announced that it has entered into a research collaboration with Pfizer ...

Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision ...

This partnership could redefine precision medicine with groundbreaking therapeutics targeting "impossible" proteins.

Atavistik Bio Inc. has entered into a research collaboration with Pfizer Inc. to accelerate the discovery of novel precision allosteric therapeutics for unmet medical needs. Under the collaboration, ...

Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics: Cambridge, Massachusetts Friday, January 3, 2025, 15:00 ...

Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two ...

Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated targets Atavistik ...

Collaboration with Pfizer will enable Atavistik Bio to extend the reach of its platform to potentially address a broader range of oncology indications, while simultaneously progressing its ...

(RTTNews) - Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to accelerate the discovery of novel precision ...